drugset
drugset / Trial / NCT00445328

Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

NCT00445328 ↗

Phase 4 Terminated 84 enrolled Pfizer
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to compare the efficacy and safety of dalteparin vs unfractionated heparin for the prevention of VTE (Venous Thromboembolism) in hospitalized acutely ill medical patients.

Timeline

Start
2007-06
Primary completion
2008-07
Completion
2008-07

Outcome

Outcome not reported

Stopped: “See Detailed Description”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalteparin sodium Other / unclassified 5000 iu Subcutaneous
Comparator HEPARIN CALCIUM Other / unclassified 5000 iu Subcutaneous

Indications

venous thromboembolism